Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Specialty & Oncology August 2020
Read Digital Edition
Advances in the Management of Sickle Cell Disease
Three novel agents were recently approved to reduce the incidence of vaso-occlusive pain crises and/or anemia in sickle cell patients.
Guest Editorial: Assuming the Front Line of ADR Reporting
Pharmacists can contribute to the evolving understanding of the postmarketing surveillance that can lead to official FDA labeling updates and, perhaps, future medication-use recommendations.
Hemophilia Review
In recent years, a number of new drugs have been FDA-approved to treat this bleeding disorder, and recent trial data on gene therapy are promising.
March 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
Pain Management
• March 2026
• 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
Cardiovascular
• February 2026
• 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Neurology
• January 2026
• 2.00 Credits
Concussion Management and Prevention
×
Full Image